Skip to main content

This post may contain affiliate links which may compensate us based on your interaction. Please read the disclosures for more information.

 Where do the most patients have access to GLP-1 meds — and which states are struggling to keep up? 

Louisville, Kentucky
f11photo / Shutterstock.com

GLP-1 receptor agonists, medications originally developed for managing type 2 diabetes, have rapidly emerged as highly effective treatment options for obesity. Medications such as semaglutide (branded as Ozempic and Wegovy) work by mimicking a natural hormone that regulates both appetite and blood sugar. These drugs have been shown to facilitate significant weight loss…

 Read More 

Leave a Reply